Glyburide During Pregnancy: Safety and Evidence

What does the evidence say about glyburide during pregnancy?

1. Glyburide was once thought not to cross the placenta, but more recent research shows this isn't accurate, and ACOG has moved away from recommending it as a first-line gestational diabetes medication. 1
2. In a network meta-analysis, glyburide had the highest probability, 94%, of being the worst option among common gestational diabetes medications for neonatal hypoglycemia, while metformin ranked best. Glyburide also showed a 91% probability of being the worst option for controlling birth weight. 2
3. Compared with insulin, glyburide has been linked to a higher risk of NICU admission, respiratory distress, hypoglycemia, and birth injury in the newborn. 1
4. Glyburide is generally considered compatible with breastfeeding, since only a small fraction of the maternal dose, well under 2%, is estimated to reach a breastfed infant based on available data. 3
5. Glyburide works by increasing insulin release from the pancreas, and while some clinical guidance has introduced it as a possible alternative to insulin, its original FDA classification and evolving safety data mean it isn't used as an equivalent first choice. 4

Is glyburide safe in each trimester?

• First trimester. Gestational diabetes is usually screened for later in pregnancy, so glyburide isn't typically a first-trimester question. If you have preexisting diabetes instead, insulin and metformin are the more established first-trimester options.
• Second trimester. Gestational diabetes is usually identified around 24 to 28 weeks, and if diet and exercise alone aren't controlling blood sugar, glyburide is one oral option, though current guidance favors insulin or metformin first given glyburide's weaker track record on newborn outcomes.
• Third trimester. Because glyburide crosses the placenta, closer blood sugar monitoring and attention to fetal growth continue through the third trimester, and your baby's blood sugar will be checked after birth given the higher documented risk of neonatal hypoglycemia.